Anticalins in Drug Development
Toward Personalized Immunotherapy for Non-Hodgkin Lymphoma : Targeting the Idiotypic Immunoglobulin
Mechanisms of Action for Treatments in Multiple Sclerosis : Does a Heterogeneous Disease Demand a Multi-Targeted Therapeutic Approach?
The Role of Radioimmunotherapy with Yttrium-90 Ibritumomab Tiuxetan in the Treatment of Non-Hodgkin Lymphoma
Spotlight on Subcutaneous Recombinant Interferon-β-1a (Rebif®) in Relapsing-Remitting Multiple Sclerosis1
Darbepoetin Alfa : Its Use in Anemia Associated with Chronic Kidney Disease